RESÚMENES NOVIEMBRE 2005

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

 

Adherence to guidelines for treatment of depression in in-patients

FRANK SCHNEIDER, MARTIN HÄRTER, SILKE BRAND, PETRA SITTA, RALPH MENKE, URSULA HAMMER-FILIPIAK, RALF KUDLING, ANDREA HEINDL, KURT HEROLD, ULRICH FROMMBERGER, OLIVIER ELMER, GÜNTER HETZEL, GABRIELE WITT, MANFRED WOLFERSDORF, MATHIAS BERGER, WOLFGANG GAEBEL

The British Journal of Psychiatry (2005) 187: 462-469

Reduced NAA Levels in the Dorsolateral Prefrontal Cortex of Young Bipolar Patients

Roberto B. Sassi, Jeffrey A. Stanley, David Axelson, Paolo Brambilla, Mark A. Nicoletti, Matcheri S. Keshavan, Renato T. Ramos, Neal Ryan, Boris Birmaher, Jair C. Soares

Am J Psychiatry 162:2109-2115, November 2005

Risk Factors for Suicide Completion in Major Depression: A Case-Control Study of Impulsive and Aggressive Behaviors in Men

A. Dumais, A.D. Lesage, M. Alda, G. Rouleau, M. Dumont, N. Chawky, M. Roy, J.J. Mann, C. Benkelfat, Gustavo Turecki

Am J Psychiatry 162:2116-2124, November 2005

A 20-Month, Double-Blind, Maintenance Trial of Lithium Versus Divalproex in Rapid-Cycling Bipolar Disorder

Joseph R. Calabrese, Melvin D. Shelton, Daniel J. Rapport, Eric A. Youngstrom, Kelly Jackson, Sarah Bilali, Stephen J. Ganocy, Robert L. Findling

Am J Psychiatry 162:2152-2161, November 2005

Lithium Placental Passage and Obstetrical Outcome: Implications for Clinical Management During Late Pregnancy

D. Jeffrey Newport, Adele C. Viguera, Aquila J. Beach, James C. Ritchie, Lee S. Cohen, Zachary N. Stowe

Am J Psychiatry 162:2162-2170, November 2005

Magnetic resonance imaging in patients with obsessive–compulsive disorder with good versus poor insight

Martin Aigner, Werner Zitterl, Daniela Prayer, Ulrike Demal, Michael Bach, Lucas Prayer, Thomas Stompe and Gerhard Lenz

Psychiatry Research: Neuroimaging. Volume 140, Issue 2, 30 November 2005, Pages 173-179

 

Seasonal Affective Disorder and Its Prevention by Anticipatory Treatment with Bupropion XL

Jack G. Modell, Norman E. Rosenthal, April E. Harriett, Alok Krishen, Afsaneh Asgharian, Vicki J. Foster, Alan Metz, Carol B. Rockett and Donna S. Wightman

Biological Psychiatry. Volume 58, Issue 8, 15 October 2005, Pages 658-667

 

Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder
Perahia DG, Kajdasz DK, Desaiah D, Haddad PM

Affect Disord. 2005 Oct 30; [Epub ahead of print]

 

Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project

Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, Yohanna D, Khan A, Alpert J

Acta Psychiatr Scand 2005: 1–10

 

Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed
Egeland J, Lund A, Landrø NI, Rund BR, Sundet K, Asbjørnsen A, Mjellem N, Roness A, Stordal KI

Acta Psychiatr Scand 2005: 1–9

 

A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients
Markowitz JC, Kocsis JH, Bleiberg KL, Christos PJ, Sacks M

J Affect Disord. 2005 Oct 29; [Epub ahead of print]

 

Nutrition and depression: implications for improving mental health among childbearing-aged women
Bodnar LM, Wisner KL

Biol Psychiatry. 2005 Nov 1;58(9):679-85. Epub 2005 Jul 25

 

Cigarette smoking and panic attacks among young adults in the community: the role of parental smoking and anxiety disorders
Goodwin RD, Lewinsohn PM, Seeley JR

Biol Psychiatry. 2005 Nov 1;58(9):686-93. Epub 2005 Jul 12

 

The munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands
Modell S, Ising M, Holsboer F, Lauer CJ

Biol Psychiatry. 2005 Nov 1;58(9):694-9. Epub 2005 Jul 14

 

Bipolar family history of the hypomanic symptoms and dimensions of mixed depression

Franco Benazzi

Comprehensive Psychiatry. Volume 46, Issue 6, November-December 2005, Pages 399-404

 

Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores

Henricus G. Ruhé, Jack J. Dekker, Jaap Peen, Rebecca Holman and Frans de Jonghe

Comprehensive Psychiatry. Volume 46, Issue 6, November-December 2005, Pages 417-427

 

Increased personality disorders and Axis I comorbidity in atypical depression

Lata K. McGinn, Gregory M. Asnis, Sonia Suchday and Margaret Kaplan

Comprehensive Psychiatry. Volume 46, Issue 6, November-December 2005, Pages 428-432

 

Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes
Spijkerman T, de Jonge P, van den Brink RH, Jansen JH, May JF, Crijns HJ, Ormel J

Gen Hosp Psychiatry. 2005 Nov-Dec;27(6):411-7

 

The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients
Schule C, Baghai TC, Alajbegovic L, Schwarz M, Zwanzger P, Eser D, Schaaf L, Moller HJ, Rupprecht R

Eur Arch Psychiatry Clin Neurosci. 2005 Oct;255(5):334-340

 

Dysfunctional baroreflex regulation of sympathetic nerve activity in remitted patients with panic disorder A new methodological approach
Shioiri T, Kojima-Maruyama M, Hosoki T, Kitamura H, Tanaka A, Yoshizawa M, Bando T, Someya T

Eur Arch Psychiatry Clin Neurosci. 2005 Oct;255(5):293-298

 

A longitudinal study of psychiatric symptoms in primiparous women: relation to personality disorders and sociodemographic factors

Borjesson K, Ruppert S, Bagedahl-Strindlund M

Arch Women Ment Health. 2005 Nov;8(4):232-242

 

Use of antidepressants by pregnant women: Evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making
Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A

Arch Women Ment Health. 2005 Nov;8(4):214-220

 

Science review: Carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
Lheureux PE, Penaloza A, Zahir S, Gris M

Crit Care. 2005 Oct 5;9(5):431-40

 

Bipolar family history of the hypomanic symptoms and dimensions of mixed depression
Benazzi F

Compr Psychiatry. 2005 November - December;46(6):399-404

 

Discontinuation syndrome following late pregnancy exposure to antidepressants
Koren G

Arch Pediatr Adolesc Med. 2004 Apr;158(4):307-8

 

Heterozygous beta-thalassaemia as a susceptibility factor in mood disorders: excessive prevalence in bipolar patients
Bocchetta A

Clin Pract Epidemol Ment Health. 2005 Jun 1;1(1):6

 

Transcranial Magnetic Stimulation for the Treatment of Depression in Neurologic Disorders
Felipe Fregni and Alvaro Pascual-Leone
Current Psychiatry Reports 2005, 7:381-390

 

Predictive Effects of Previous Episodes on the Risk of Recurrence in Depressive and Bipolar Disorders
Lars Vedel Kessing and Per Kragh Andersen
Current Psychosis & Therapeutics Reports 2005, 3:123-130

 

The Relationship of Major Depressive Disorder to Bipolar Disorder: Continuous or Discontinuous?
Franco Benazzi
Current Psychosis & Therapeutics Reports 2005, 3:131-139

 

Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: an fMRI study
Peter H Silverstone, Emily C Bell, Morgan C Willson, Sanjay Dave and Alan H Wilman
Annals of General Psychiatry 2005, 4:14; 19 July 2005

 

Effect of Bupropion on Sexual Dysfunction

Regina Ginzburg, Yvonne Wong, Jonathan S Fader

The Annals of Pharmacother. Nov 15, 2005

 

The Epidemiology of Social Anxiety Disorder in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Bridget F. Grant, Deborah S. Hasin, Carlos Blanco, Frederick S. Stinson, S. Patricia Chou, Rise B. Goldstein, Deborah A. Dawson, Sharon Smith, Tulshi D. Saha, and Boji Huang

J Clin Psychiatry 2005;66:1351-1361

 

Typical and Atypical Antipsychotics in Bipolar Depression

Keming Gao, Prashant Gajwani, Omar Elhaj, and Joseph R. Calabrese

J Clin Psychiatry 2005;66:1376-1385

 

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

Mark H. Pollack, Peter P. Roy-Byrne, Michael Van Ameringen, Heather Snyder, Charles Brown, John Ondrasik, and Karl Rickels

J Clin Psychiatry 2005;66:1401-1408

 

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

J. Craig Nelson, Laura Portera, and Andrew C. Leon

J Clin Psychiatry 2005;66:1409-1414

 

Cognitive Therapy and Exposure in Vivo Alone and in Combination With Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up

Patricia van Oppen, Anton J. L. M. van Balkom, Else de Haan, and Richard van Dyck

J Clin Psychiatry 2005;66:1415-1422

 

Misdiagnosed Patients With Bipolar Disorder: Comorbidities, Treatment Patterns, and Direct Treatment Costs

Louis S. Matza, Krithika S. Rajagopalan, Christine L. Thompson, and Gregory de Lissovoy

J Clin Psychiatry 2005;66:1432-1440

 

Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder

Jonathan R. T. Davidson, Anjana Bose, and Qin Wang

J Clin Psychiatry 2005;66:1441-1446

 

Suicidal Ideation and Attempts in Bipolar I and II Disorders

Hanna Valtonen, Kirsi Suominen, Outi Mantere, Sami Leppämäki, Petri Arvilommi, and Erkki T. Isometsä

J Clin Psychiatry 2005;66:1456-1462

 

Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder

Scott W. Andersen, David B. Clemow, and Sara A. Corya

J Clin Psychiatry 2005;66:1468-1476

 

Sequential Treatment of Mood and Anxiety Disorders

Giovanni A. Fava, Chiara Ruini, and Chiara Rafanelli

J Clin Psychiatry 2005;66:1392-1400

 

Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter Gene
Giampaolo Perna, Elisa Favaron, Daniela Di Bella, Riccardo Bussi and Laura Bellodi

Neuropsychopharmacology (2005) 30, 2230-2235

Lack of Pharmacokinetic Interaction between Oxcarbazepine and Lamotrigine
Jochen G W Theis, Jagdev Sidhu, Joanne Palmer, Sarah Job, Jonathan Bullman and John Ascher

Neuropsychopharmacology (2005) 30, 2269-2274

Long-term lithium treatment and thyroid antibodies: a controlled study

Christopher Baethge, Holger Blumentritt, Anne Berghöfer, Tom Bschor, Tasha Glenn, Mazda Adli, Peter Schlattmann, Michael Bauer, Reinhard Finke

J Psychiatry Neurosci 2005;30(6):423-7

 

Bifrontal Versus Right Unilateral and Bitemporal Electroconvulsive Therapy in Major Depressive Disorder
Ranjkesh, Farzad; Barekatain, Majid; Akuchakian, Shahla

Journal of ECT. 21(4):207-210, December 2005

What Do Psychiatrists Mean by Medication Resistance as an Indication for Electroconvulsive Therapy?
Husain, Syed S; Kevan, Ian Mark; Linnell, Rebecca; Scott, Allan I F

Journal of ECT. 21(4):211-213, December 2005

Long-Term Follow-Up in Depressed Patients Treated With Electroconvulsive Therapy
Johanson, Aki; Gustafson, Lars; Risberg, Jarl; Rosen, Ingmar; Sjobeck, Martin; Silfverskiold, Peter

Journal of ECT. 21(4):214-220, December 2005

One-Year Outcome of Psychotic Depression After Successful Electroconvulsive Therapy
Birkenhager, Tom K; van den Broek, Walter W; Mulder, Paul G H; de Lely, Ariejan

Journal of ECT. 21(4):221-226, December 2005

Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies
Clayton AH, Stewart RS, Fayyad R, Clary CM

Arch Women Ment Health. 2005 Nov 15; [Epub ahead of print]

 

Psychosocial and demographic factors associated with response to prophylactic lithium. A systematic review for bipolar disorders

N. KLEINDIENST, R. R. ENGEL and W. GREIL

Psychological Medicine (2005), 35: 1685-1694

 

Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project

ELLEN B. DENNEHY, TRISHA SUPPES, A. JOHN RUSH, ALEXANDER L. MILLER, MADHUKAR H. TRIVEDI, M. LYNN CRISMON, THOMAS J. CARMODY and T. MICHAEL KASHNER

Psychological Medicine (2005), 35: 1695-1706

 

Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions

BRIDGET F. GRANT, DEBORAH S. HASIN, FREDERICK S. STINSON, DEBORAH A. DAWSON, W. JUNE RUAN, RISË B. GOLDSTEIN, SHARON M. SMITH, TULSHI D. SAHA and BOJI HUANG

Psychological Medicine (2005), 35: 1747-1759

 

Depression in Pregnancy and the Postpartum Period: Balancing Adverse Effects of Untreated Illness with Treatment Risks
MIAN, AYESHA I.

Journal of Psychiatric Practice. 11(6):389-396, November 2005

Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm

Y Kohn and B Lerer

Molecular Psychiatry (2005) 10, 1062–1073

 

Antidepressant combinations: epidemiological considerations
Agüera LF, Rojo JE, Ros S, de la Gándara J, de Pedro JM

Acta Psychiatr Scand 2005: 112 (Suppl. 428): 7–10

 

Neuropharmacological basis of combining antidepressants
de la Gándara J, Rojo JE, Ros S, Agüera L, de Pedro JM

Acta Psychiatr Scand 2005: 112 (Suppl. 428): 11–13

 

Potentiation strategies for treatment-resistant depression
Ros S, Agüera L, de la Gándara J, Emilio Rojo J, de Pedro JM

Acta Psychiatr Scand 2005: 112 (Suppl. 428): 14–24

 

Combined antidepressants: clinical experience
Rojo JE, Ros S, Agüera L, de la Gándara J, de Pedro JM

Acta Psychiatr Scand 2005: 112 (Suppl. 428): 25–31

 

Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder
Blumberg HP, Donegan NH, Sanislow CA, Collins S, Lacadie C, Skudlarski P, Gueorguieva R, Fulbright RK, McGlashan TH, Gore JC, Krystal JH

Psychopharmacology (Berl). 2005 Oct 26;:1-6

 

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

Johanna Palmio, Martti Huuhka, Pirjo Saransaari, Simo S. Oja, Jukka Peltola, Esa Leinonen, Jaana Suhonen and Tapani Keränen

Psychiatry Research. Volume 137, Issue 3, 15 December 2005, Pages 183-190

 

Depressive disorders—is it time to endorse different pathophysiologies?

Irina A. Antonijevic

Psychoneuroendocrinology. Volume 31, Issue 1, January 2006, Pages 1-15

 

The Relationship of Major Depressive Disorder to Bipolar Disorder: Continuous or Discontinuous?

 

Franco Benazzi

Current Psychiatry Reports 2005, 7:462-470

 

 

 

The Impact of Residual Symptoms on Outcome of Major Depression

Noel Kennedy and Kevin Foy

Current Psychiatry Reports 2005, 7:441-446

 

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder
Hirschfeld, Robert; Eerdekens, Marielle; Kalali, Amir H; Canuso, Carla M; Khan, Akbar A; Karcher, Keith; Palumbo, Joseph M

International Clinical Psychopharmacology. 21(1):11-20, January 2006

Clinical characteristics of depressed patients with comorbid diabetes mellitus
Petersen, Timothy; Iosifescu, Dan V; Papakostas, George I; Shear, Deborah L; Fava, Maurizio

International Clinical Psychopharmacology. 21(1):43-47, January 2006

.

Regresar a RESÚMENES NOVIEMBRE 2005